REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulatio
REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulation studies for In Vitro Diagnostic Use.PRINCIPLE OF THE PROCEDURECoagulation Control 2 is tested in the same manner as citrated patient plasma samples to assess the performance of each assay run, for the parameters. Testing variables in each laboratory, including equipment, reagents, and technique may influence control recovery. Although an expected range is provided for each parameter, laboratories should establish their own expected range for their particular instrument-reagent system. Refer to Package Insert.
Assayed control used to monitor the performance of coagulation assays in the pat
Assayed control used to monitor the performance of coagulation assays in the pathological range
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant c
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers
LA Control High is a high positive control plasma for use in Lupus Anticoagulant
LA Control High is a high positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers
LA 2 Confirmation Reagent. Phospholipid-rich DRVV reagent for the specific corre
LA 2 Confirmation Reagent. Phospholipid-rich DRVV reagent for the specific correction of Lupus Anticoagulants
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lu
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants
For use as a high level assayed control for the quantitative measurement of low
For use as a high level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin
For use as a high level assayed control for the quantitative measurement of unfr
For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
George King Factor XIII Deficient plasma is fresh frozen human plasma derived fr
George King Factor XIII Deficient plasma is fresh frozen human plasma derived from a congenital Factor XIII deficient donor.